Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer.
Sharma S, Chandra K, Naik A, Sharma A, Sharma R, Thakur A, Grewal AS, Dhingra AK, Banerjee A, Liou JP, Guru SK, Nepali K. Sharma S, et al. Among authors: sharma r, sharma a. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2276665. doi: 10.1080/14756366.2023.2276665. Epub 2023 Nov 2. J Enzyme Inhib Med Chem. 2023. PMID: 37919954 Free PMC article.
Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
Chary PS, Bansode A, Rajana N, Bhavana V, Singothu S, Sharma A, Guru SK, Bhandari V, Mehra NK. Chary PS, et al. Among authors: sharma a. Int J Pharm. 2024 May 25;657:124109. doi: 10.1016/j.ijpharm.2024.124109. Epub 2024 Apr 16. Int J Pharm. 2024. PMID: 38626846
Corrigendum to "Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies" [Int. J. Biol. Macromol. 282 (2024) 136600].
Mahajan S, Aalhate M, Chatterjee E, Singh H, Sharma A, Maji I, Gupta U, Guru SK, Singh PK. Mahajan S, et al. Among authors: sharma a. Int J Biol Macromol. 2025 Jan;284(Pt 2):138183. doi: 10.1016/j.ijbiomac.2024.138183. Epub 2024 Dec 3. Int J Biol Macromol. 2025. PMID: 39626613 No abstract available.
Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer.
Shah S, Famta P, Kumar R, Sharma A, Vambhurkar G, Pandey G, Singh G, Kumar P, Mehra A, Mourya A, Srinivasarao DA, Shinde A, Prasad SB, Khatri DK, Madan J, Srivastava S. Shah S, et al. Among authors: sharma a. Colloids Surf B Biointerfaces. 2024 Feb;234:113732. doi: 10.1016/j.colsurfb.2023.113732. Epub 2023 Dec 27. Colloids Surf B Biointerfaces. 2024. PMID: 38181691
Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability.
Shah S, Famta P, Vambhurkar G, Bagasariya D, Kumar KC, Srinivasarao DA, Begum N, Sharma A, Shahrukh S, Jain N, Khatri DK, Srivastava S. Shah S, et al. Among authors: sharma a. Drug Deliv Transl Res. 2024 May;14(5):1218-1231. doi: 10.1007/s13346-023-01453-1. Epub 2023 Oct 30. Drug Deliv Transl Res. 2024. PMID: 37903963
23,303 results
You have reached the last available page of results. Please see the User Guide for more information.